Having trouble accessing articles? Reset your cache.

MoxDuo IV: Phase II data

In a double-blind, active-controlled, German Phase II trial in 40 patients, SPID scores at 65 minutes post-dosing were 50% higher for MoxDuo IV vs. IV morphine alone, with 67% of MoxDuo IV

Read the full 324 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE